- Home
- CLYM vs PEBK Comparison
CLYM vs PEBK Comparison
Compare CLYM & PEBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLYM
- PEBK
- Stock Information
- Founded
- CLYM 2018
- PEBK 1912
- Country
- CLYM United States
- PEBK United States
- Employees
- CLYM N/A
- PEBK N/A
- Industry
- CLYM
- PEBK Major Banks
- Sector
- CLYM
- PEBK Finance
- Exchange
- CLYM NYSE
- PEBK Nasdaq
- Market Cap
- CLYM 201.7M
- PEBK 169.6M
- IPO Year
- CLYM 2021
- PEBK N/A
- Fundamental
- Price
- CLYM $1.95
- PEBK $31.20
- Analyst Decision
- CLYM
- PEBK
- Analyst Count
- CLYM 0
- PEBK 0
- Target Price
- CLYM N/A
- PEBK N/A
- AVG Volume (30 Days)
- CLYM 264.1K
- PEBK 31.0K
- Earning Date
- CLYM 11-12-2024
- PEBK 01-21-2025
- Dividend Yield
- CLYM N/A
- PEBK 2.40%
- EPS Growth
- CLYM N/A
- PEBK 1.99
- EPS
- CLYM N/A
- PEBK 2.95
- Revenue
- CLYM N/A
- PEBK $79,995,000.00
- Revenue This Year
- CLYM N/A
- PEBK N/A
- Revenue Next Year
- CLYM N/A
- PEBK N/A
- P/E Ratio
- CLYM N/A
- PEBK $10.75
- Revenue Growth
- CLYM N/A
- PEBK 3.47
- 52 Week Low
- CLYM $1.86
- PEBK $23.74
- 52 Week High
- CLYM $11.55
- PEBK $33.31
- Technical
- Relative Strength Index (RSI)
- CLYM N/A
- PEBK 60.99
- Support Level
- CLYM N/A
- PEBK $30.75
- Resistance Level
- CLYM N/A
- PEBK $32.65
- Average True Range (ATR)
- CLYM 0.00
- PEBK 0.78
- MACD
- CLYM 0.00
- PEBK -0.20
- Stochastic Oscillator
- CLYM 0.00
- PEBK 41.41
About CLYM CLIMB BIO INC
Climb Bio Inc is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. its lead product candidate, budoprutug, is an anti-CD19 monoclonal antibody that has demonstrated B-cell depletion and has the potential to treat a broad range of B-cell-mediated diseases.
About PEBK Peoples Bancorp of North Carolina Inc.
Peoples Bancorp of North Carolina Inc is a bank holding company. It is a state-chartered commercial bank serving Lincolnton, Newton, Denver, Catawba, Conover, Maiden, Claremont, Hiddenite, Hickory, Charlotte, Cornelius, Raleigh, and Cary, North Carolina. It has a diversified loan portfolio with no foreign loans and few agricultural loans. The company's main source of income is dividends declared and paid by the Bank on its capital stock.